Join our community of smart investors

Finsbury Foods goes gluten-free

The bakery company has acquired gluten-free baked goods maker Ultrapharm since the period end
September 18, 2018

Finsbury Food (FIF) chief executive John Duffy referred to this set of results as a “step forward in a difficult period”. The bakery boss said added costs, from higher prices for ingredients such as butter and flour to the new national living wage, acted as a headwind during the period. Closure of the lossmaking Grain D’Or factory added to these costs. Together, this meant that pre-tax profits fell two-thirds to £4.5m, but strip out these factors and this metric was up 4 per cent to £17.2m. The group is attempting to offset some of these cost increases by becoming more efficient, including automating parts of the production line.

IC TIP: Buy at 124p

Since the period-end, Finsbury Foods has moved further into the gluten-free market with the acquisition of Ultrapharm for £17m in cash at completion plus a deferred consideration of £3m. Mr Duffy said the deal would give the group access to the high-growth 'free from' market, as well as expand its manufacturing capabilities in Europe and increase the group’s scale.

Analysts at Panmure Gordon expect adjusted pre-tax profits of £19m during the year to June 2019, giving EPS of 10.8p, compared with £17.9m and 9.8p in FY2018.

FINSBURY FOOD (FIF)  
ORD PRICE:124pMARKET VALUE:£162m
TOUCH:123-125p12-MONTH HIGH:131pLOW: 99p
DIVIDEND YIELD:2.7%PE RATIO:73
NET ASSET VALUE:79p*NET DEBT:15%
Year to 30 JunTurnover (£m)Pre-tax profit (£m)Earnings per share (p)Dividend per share (p)
20141766.66.71.0
20152568.55.82.5
201632011.86.12.8
201731413.07.13.0
20183044.51.73.3
% change-3-66-76+10
Ex-div:22 Nov   
Payment:21 Dec   
*Includes £83.3m of intangible assets, or 64p a share